Wen-hui Ku
Taipei, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Tumor Immune Response as a Biomarker for Metastasis-Free Survival of Breast Cancer and Immune Checkpoint Inhibition Therapy: A Retrospective Cohort Study.
Journal: Breast cancer : basic and clinical research
Published: January 24, 2025
Deciphering Genetic Alterations of Taiwanese Patients with Pancreatic Adenocarcinoma through Targeted Sequencing.
Journal: International journal of molecular sciences
Published: January 02, 2022
The Ring Study: an international comparison of PD-L1 diagnostic assays and their interpretation in non-small cell lung cancer, head and neck squamous cell cancer and urothelial cancer.
Journal: Pathology
Published: December 27, 2021
Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non-small-cell lung cancer: a multicenter study using targeted next-generation sequencing.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 21, 2021
Atherosclerotic cardiovascular disease screening and management protocols among adult HIV clinics in Asia.
Journal: Journal of virus eradication
Published: March 17, 2020
Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial.
Journal: The Lancet. Infectious diseases
Published: August 13, 2019
Liquid biopsy for detection of EGFR T790M mutation in nonsmall cell lung cancer: An experience of proficiency testing in Taiwan.
Journal: Journal of the Chinese Medical Association : JCMA
Published: April 02, 2019
High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment naïve advanced EGFR-mutant lung adenocarcinoma patients.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 13, 2018
Characteristics and Predictive Value of PD-L1 Status in Real-World Non-Small Cell Lung Cancer Patients.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: April 24, 2018
FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 11, 2017
Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma.
Journal: American journal of cancer research
Published: February 05, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026